Finucane Anne A. 4

What Happened

• Anne A. Finucane, a director of Williams‑Sonoma (WSM), had 1,280 restricted stock units (RSUs) convert/exercise on June 11, 2026. The filing reports an exercise/conversion (transaction code M) for 1,280 shares with an exercise price of $0.00 (reported value $0). There was no open‑market sale — this is a vesting/conversion of company equity compensation rather than a purchase or sale.

Key Details

• Transaction date: 2026-06-11; reported on Form 4 filed 2026-06-12 (timely).
• Reported amounts: 1,280 shares acquired via conversion and 1,280 shares reported as disposition of the derivative instrument (both at $0.00).
• Shares owned after transaction: not specified in the provided filing details.
• Footnotes of note:
  • F1: Each RSU represents a contingent right to one share of WSM common stock.
  • F3: The RSUs fully vested on June 11, 2026.
  • F2: Vested shares will be delivered at the end of a deferral period on June 11, 2027 (or earlier upon certain events), so actual share delivery may be deferred despite the conversion being reported.
• Transaction code M indicates an exercise or conversion of a derivative security (here, RSUs).

Context

• This is a routine compensation vesting/conversion event, not a market purchase or sale. The filing shows no cash paid (exercise price $0) and no immediate open‑market sale; because delivery can be deferred under the plan, Finucine may not yet have received the underlying shares. Such conversions are common for directors as part of equity compensation and do not by themselves signal a change in insider sentiment.